Genworth Financial Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.175 |
| EPS actual | $0.280 |
| EPS Surprise | 60.00% |
| Revenue estimate | 1.723B |
| Revenue actual | 1.777B |
| Revenue Surprise | 3.13% |
| Release date | Feb 23, 2026 |
| EPS estimate | $0.160 |
| EPS actual | $0.0200 |
| EPS Surprise | -87.50% |
| Revenue estimate | 1.493B |
| Revenue actual | 1.784B |
| Revenue Surprise | 19.49% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.100 |
| EPS actual | $0.0400 |
| EPS Surprise | -60.00% |
| Revenue estimate | - |
| Revenue actual | 1.873B |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.0600 |
| EPS actual | $0.160 |
| EPS Surprise | 166.67% |
| Revenue estimate | - |
| Revenue actual | 1.727B |
Last 4 Quarters for Genworth Financial
Below you can see how GNW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $7.93 |
| EPS estimate | $0.0600 |
| EPS actual | $0.160 |
| EPS surprise | 166.67% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $7.34 |
| Jul 25, 2025 | $8.00 |
| Jul 28, 2025 | $8.11 |
| Jul 29, 2025 | $8.00 |
| Jul 30, 2025 | $7.93 |
| Jul 31, 2025 | $7.86 |
| Aug 01, 2025 | $7.85 |
| Aug 04, 2025 | $7.86 |
| Aug 05, 2025 | $7.96 |
| 4 days before | 8.04% |
| 4 days after | 0.378% |
| On release day | -0.88% |
| Change in period | 8.45% |
| Release date | Nov 05, 2025 |
| Price on release | $8.57 |
| EPS estimate | $0.100 |
| EPS actual | $0.0400 |
| EPS surprise | -60.00% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $8.42 |
| Oct 31, 2025 | $8.44 |
| Nov 03, 2025 | $8.45 |
| Nov 04, 2025 | $8.53 |
| Nov 05, 2025 | $8.57 |
| Nov 06, 2025 | $8.59 |
| Nov 07, 2025 | $8.67 |
| Nov 10, 2025 | $8.63 |
| Nov 11, 2025 | $8.49 |
| 4 days before | 1.78% |
| 4 days after | -0.93% |
| On release day | 0.233% |
| Change in period | 0.83% |
| Release date | Feb 23, 2026 |
| Price on release | $8.30 |
| EPS estimate | $0.160 |
| EPS actual | $0.0200 |
| EPS surprise | -87.50% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $9.00 |
| Feb 18, 2026 | $8.86 |
| Feb 19, 2026 | $8.78 |
| Feb 20, 2026 | $8.78 |
| Feb 23, 2026 | $8.30 |
| Feb 24, 2026 | $8.55 |
| Feb 25, 2026 | $8.51 |
| Feb 26, 2026 | $8.65 |
| Feb 27, 2026 | $8.44 |
| 4 days before | -7.78% |
| 4 days after | 1.69% |
| On release day | 3.01% |
| Change in period | -6.22% |
| Release date | May 05, 2026 |
| Price on release | $8.87 |
| EPS estimate | $0.175 |
| EPS actual | $0.280 |
| EPS surprise | 60.00% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $8.97 |
| Apr 30, 2026 | $8.79 |
| May 01, 2026 | $8.81 |
| May 04, 2026 | $8.87 |
| May 05, 2026 | $8.87 |
| May 06, 2026 | $9.17 |
| May 07, 2026 | $9.14 |
| May 08, 2026 | $9.13 |
| May 11, 2026 | $9.06 |
| 4 days before | -1.11% |
| 4 days after | 2.14% |
| On release day | 3.38% |
| Change in period | 1.00% |
Genworth Financial Earnings Call Transcript Summary of Q1 2026
Genworth reported Q1 2026 net income of $47 million and updated its reporting approach to exclude the Closed Block from consolidated adjusted operating income to better reflect ongoing operations (adjusted operating income excl. Closed Block: $109 million). Enact delivered strong performance (Genworth's share of Enact book value ~$4.3 billion; Enact adjusted operating income to Genworth: $140 million) and provided $99 million of capital returns in Q1; Genworth expects ~$405–450 million from Enact for full-year 2026. Genworth continues share repurchases (year-to-date repurchases and a 2026 buyback target of $195–225 million) and reduced holding company debt to $778 million. CareScout is being scaled as Genworth's long-term growth engine: Q1 CareScout service revenue was $6 million, with a 2026 target of $25 million, planned investment of $50–55 million, and a target of ~7,500 matches in 2026 (including senior living). The Closed Block remains managed as a self-sustaining portfolio; Q1 reported an adjusted operating loss of $32 million with expected full-year A-to-E GAAP losses around $300 million (which management says do not affect cash flows or economic value). Key priorities remain: grow Enact and CareScout, maintain Closed Block sustainability via MYRAP actions, return capital to shareholders, and opportunistically retire debt.
Sign In
Buy GNW